Predict your next investment

Corporation
HEALTHCARE | Biotechnology
fluidigm.com

See what CB Insights has to offer

Founded Year

1999

Stage

IPO | IPO

Total Raised

$142.7M

Date of IPO

2/10/2011

Market Cap

0.24B

Stock Price

3.13

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including 18 different commercial integrated fluidic circuits for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing the excellent data quality demanded by customers.

Fluidigm Headquarter Location

7000 Shoreline Court Suite 100

South San Francisco, California, 94080,

United States

650-266-6000

Latest Fluidigm News

Protein Microarray Market to record USD 1.48 Bn growth | 5.98 % YOY growth expected in 2022 | Technavio

Jan 12, 2022

| Technavio News provided by Share this article Share this article NEW YORK, Jan. 11, 2022 /PRNewswire/ -- The protein microarray market size is expected to grow by USD 1.48 billion from 2021 to 2026, progressing at a CAGR of  8.92%. Globally, the prevalence of chronic diseases, such as cancer is increasing continuously. This is creating the need for cancer research and diagnostics that involve the use of molecular biology techniques such as DNA sequencing and DNA protein microarrays. In addition, increasing investments in R&D on the development of new drugs by pharmaceutical companies are creating several growth opportunities in the market. Attractive Opportunities in Protein Microarray Market Explore future growth opportunities and stay informed by purchasing our full report. Factors such as an increase in the adoption of microarrays in genomics and proteomics and the rising prevalence of chronic diseases will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. Protein Microarray Market 2022-2026: Segmentation Class Type ROW By type, the market is observed high growth in the analytical protein microarrays segment in 2020. The market growth in the segment will be significant during the forecast period. By geography, North America will offer maximum growth opportunities for market players. The region currently holds 38% of the global market share. Increasing investments in healthcare research and testing in the US is one of the major factors driving the growth of the protein microarray market in North America. Also, increasing healthcare expenditure and higher production of pharmaceutical products, such as drugs, vaccines, and monoclonal antibodies for the treatment of patients with various diseases are contributing to the growth of the regional market. Download Our Full Sample  for highlights on top-performing segments, regions, and key countries in the market. Protein Microarray Market 2022-2026: Vendor Analysis and Scope The protein microarray market is fragmented, and the degree of fragmentation will accelerate during the forecast period. The market s characterized by the presence of numerous players competing in terms of R&D, quality, price, innovations, marketing strategies, market expansion, investments, and distribution networks. Some of the major vendors of the protein microarray market include Agilent Technologies Inc., Bio Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., Illumina Inc., Merck and Co. Inc., Molecular Devices LLC, PerkinElmer Inc., RayBiotech Life Inc., and Thermo Fisher Scientific Inc. To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. Backed with competitive intelligence and benchmarking, our research reports on the protein microarray market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support. The increase in the adoption of microarrays in genomics and proteomics will offer immense growth opportunities. However, the standardization and accuracy issues will hamper the market growth. Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000 . View 3 reports monthly and Download 3 Reports Annually! Protein Microarray Market 2022-2026: Key Highlights CAGR of the market during the forecast period 2022-2026 Detailed information on factors that will assist protein microarray market growth during the next five years Estimation of the protein microarray market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the protein microarray market Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of protein microarray market vendors Related Reports: Companies profiled Agilent Technologies Inc., Bio Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., Illumina Inc., Merck and Co. Inc., Molecular Devices LLC, PerkinElmer Inc., RayBiotech Life Inc., and Thermo Fisher Scientific Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Fluidigm

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fluidigm is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,889 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

O

Omics

1,213 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Fluidigm Patents

Fluidigm has filed 133 patents.

The 3 most popular patent topics include:

  • Mass spectrometry
  • Molecular biology
  • Ion source
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/16/2016

9/14/2021

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics

Grant

Application Date

12/16/2016

Grant Date

9/14/2021

Title

Related Topics

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics

Status

Grant

Fluidigm Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fluidigm Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.